|
Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, Miller JD, Hartung O, Rho J, Ince TA, Daley GQ, Schlaeger TM. Nat Biotechnol. 2009 Oct 11.
Improved electrospray ionization efficiency compensates for diminished chromatographic resolution and enables proteomics analysis of tyrosine signaling in embryonic stem cells. Ficarro SB, Zhang Y, Lu Y, Moghimi AR, Askenazi M, Hyatt E, Smith ED, Boyer L, Schlaeger TM, Luckey CJ, Marto JA. Anal Chem. 2009 May 1;81(9):3440-7.
Derivation and maintenance of human embryonic stem cells from poor-quality in vitro fertilization embryos. Lerou PH, Yabuuchi A, Huo H, Miller JD, Boyer LF, Schlaeger TM, Daley GQ. Nat Protoc. 2008;3(5):923-33.
Inducible endothelial cell-specific gene expression in transgenic mouse embryos and adult mice. Deutsch U, Schlaeger TM, Dehouck B, Döring A, Tauber S, Risau W, Engelhardt B. Exp Cell Res. 2008 Apr 1;314(6):1202-16.
Enhanced plating efficiency of trypsin-adapted human embryonic stem cells is reversible and independent of trisomy 12/17. Chan EM, Yates F, Boyer LF, Schlaeger TM, Daley GQ. Cloning Stem Cells. 2008 Mar;10(1):107-18.
Science aside: the trajectory of embryonic stem cell research in the USA. Schlaeger TM, Lensch MW, Taylor PL. Drug Discov Today. 2007 Apr;12(7-8):269-71.
Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera. Lensch MW, Schlaeger TM, Zon LI, Daley GQ. Cell Stem Cell. 2007 Sep 13;1(3):253-8.
Pluripotent stem cells and their niches. Lensch MW, Daheron L, Schlaeger TM. Stem Cell Rev. 2006;2(3):185-201. Review.
|